tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Smart Value
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

Positive Outlook for Amgen: Buy Rating Backed by Promising Rocatinlimab and Obesity Treatment Prospects
RatingsPositive Outlook for Amgen: Buy Rating Backed by Promising Rocatinlimab and Obesity Treatment Prospects
1d ago
AMGN
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
2d ago
BMY
ABBV
Positive Outlook for Amgen’s Stock Driven by Promising Rocatinlimab Trial Results
PremiumRatings
Positive Outlook for Amgen’s Stock Driven by Promising Rocatinlimab Trial Results
2d ago
AMGN
Amgen’s Rocatinlimab Faces Challenges in Atopic Dermatitis Market: Hold Rating Maintained
PremiumRatings
Amgen’s Rocatinlimab Faces Challenges in Atopic Dermatitis Market: Hold Rating Maintained
2d ago
AMGN
Cautious Hold Rating on Amgen Amid Rocatinlimab’s Efficacy and Safety Concerns
PremiumRatings
Cautious Hold Rating on Amgen Amid Rocatinlimab’s Efficacy and Safety Concerns
2d ago
AMGN
Amgen, Kyowa announces new results from ongoing ROCKET Phase 3 study
PremiumThe FlyAmgen, Kyowa announces new results from ongoing ROCKET Phase 3 study
3d ago
AMGN
Piper Sandler healthcare analysts hold analyst/industry conference call
Premium
The Fly
Piper Sandler healthcare analysts hold analyst/industry conference call
7d ago
AMGN
Amgen’s Strategic Growth Potential Bolstered by Promising MariTide Phase III Trials
Premium
Ratings
Amgen’s Strategic Growth Potential Bolstered by Promising MariTide Phase III Trials
7d ago
AMGN
Amgen price target raised to $294 from $275 at BofA
PremiumThe Fly
Amgen price target raised to $294 from $275 at BofA
7d ago
JNJ
ABBV
Amgen, AstraZeneca announce results from Phase 3 WAYPOINT trial on tezspire
PremiumThe Fly
Amgen, AstraZeneca announce results from Phase 3 WAYPOINT trial on tezspire
10d ago
AZN
AMGN
Amgen’s Strong Growth Potential and Strategic Positioning Justify Buy Rating
PremiumRatings
Amgen’s Strong Growth Potential and Strategic Positioning Justify Buy Rating
14d ago
AMGN
Apple to invest $500B in U.S., Domino’s reports downbeat Q4: Morning Buzz
PremiumThe Fly
Apple to invest $500B in U.S., Domino’s reports downbeat Q4: Morning Buzz
16d ago
OC
APO
Amgen plans $200M investment in India site, Reuters reports
PremiumThe FlyAmgen plans $200M investment in India site, Reuters reports
16d ago
AMGN
Ideaya Biosciences price target lowered to $40 from $53 at Oppenheimer
Premium
The Fly
Ideaya Biosciences price target lowered to $40 from $53 at Oppenheimer
27d ago
AMGN
IDYA
Amgen price target raised to $329 from $310 at Piper Sandler
Premium
The Fly
Amgen price target raised to $329 from $310 at Piper Sandler
1M ago
AMGN
Amgen price target raised to $275 from $256 at BofA
PremiumThe Fly
Amgen price target raised to $275 from $256 at BofA
1M ago
AMGN
Cautious Outlook on Amgen: Sell Rating Amid Modest Growth and Competitive Pressures
PremiumRatings
Cautious Outlook on Amgen: Sell Rating Amid Modest Growth and Competitive Pressures
1M ago
AMGN
Amgen Holds Steady Amid Strong Performance and Future Challenges
PremiumRatings
Amgen Holds Steady Amid Strong Performance and Future Challenges
1M ago
AMGN
Amgen Inc. Reports Robust 2024 Growth Amid Challenges
PremiumCompany Announcements
Amgen Inc. Reports Robust 2024 Growth Amid Challenges
1M ago
AMGN
Amgen upgraded to Buy from Hold at Erste Group
PremiumThe FlyAmgen upgraded to Buy from Hold at Erste Group
1M ago
AMGN
Amgen price target raised to $328 from $322 at Morgan Stanley
Premium
The Fly
Amgen price target raised to $328 from $322 at Morgan Stanley
1M ago
AMGN
Regeneron price target raised to $575 from $565 at BofA
Premium
The Fly
Regeneron price target raised to $575 from $565 at BofA
1M ago
AMGN
REGN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >